Indivior PLC

ISIN GB00BN4HT335

 | 

WKN A3DWFC

 

Overzicht

Beschrijving

Indivior PLC is a holding company, which engages in the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence. Its products include Suboxone Film, Suboxone Tablet, and Subutex Tablet. It operates through the following geographical segments: United States, Rest of World, and United Kingdom. The company was founded on September 26, 2014 and is headquartered in North Chesterfield, VA.
Toon meer Toon minder
Healthcare Biopharmaceuticals Other Biopharmaceuticals United States

Financiële kerngegevens

Kerncijfers

Marktkapitalisatie, EUR 1,036.05 m
WPA, EUR -0.24
KBV 142.15
K/W 629.33
Dividendrendement 0.00%

Winst- en verliesrekening (2024)

Omzet, EUR 1,098.28 m
Netto-inkomen, EUR 1.85 m
Winstmarge 0.17%

In welke ETF zit Indivior PLC?

Er zijn 26 ETF's die Indivior PLC bevatten. Al deze ETF's staan in de tabel hieronder. De ETF met de grootste weging van Indivior PLC is de Deka STOXX Europe Strong Value 20 UCITS ETF.
— Gegevens verstrekt door Trackinsight, etfinfo, Xignite Inc., gettex, FactSet en justETF GmbH.

Standaard zijn ETF-rendementen inclusief dividenduitkeringen (indien van toepassing).